2. Gene
  3. Mcl1 - MCL1 apoptosis regulator, BCL2 family member Gene

Mcl1 - MCL1 apoptosis regulator, BCL2 family member Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

中文名称：MCL1 凋亡调节因子，BCL2 家族成员

种属: Rattus norvegicus

基因 ID: 60430 | 基因类型: protein coding

关于 Mcl1

Primary_assembly 2: 183,219,220-183,222,303 forward strand.mRatBN7.2:CM026975.1

This gene has 1 transcript (splice variant), 235 orthologues, 13 paralogues and is associated with 21 phenotypes. Biased expression in Spleen (RPKM 131.3), Lung (RPKM 852.7) and 9 other tissues.

功能概要

该基因编码的蛋白可启动 BH 结构域结合活性和蛋白质二聚化活性。参与细胞凋亡过程的负调控。预计位于几种细胞成分中，包括细胞质；线粒体基质；和核。预计是 Bcl-2 家族蛋白复合物的一部分。预计在线粒体外膜中有活性。与人类 MCL1 同源（MCL1 细胞凋亡调节因子，BCL2 家族成员）。 [由基因组资源联盟提供，2022 年 4 月]

Enables BH domain binding activity and protein dimerization activity. Involved in negative regulation of apoptotic process. Predicted to be located in several cellular components, including cytosol; mitochondrial matrix; and nucleus. Predicted to be part of Bcl-2 Family protein complex. Predicted to be active in mitochondrial outer membrane. Orthologous to human MCL1 (MCL1 Apoptosis regulator, BCL2 family member). [provided by Alliance of Genome Resources, Apr 2022]

Mcl1 基因产物(1)

mRNA Protein Name
NM_021846.2 NP_068618.2 induced myeloid leukemia cell differentiation protein Mcl-1 homolog
基因本体论
  • 分子功能
  • 生物过程
分子功能 GO 注释 逻辑证据 参考文献 来源
enables BH domain binding IPI
IPI: 通过物理相互作用推断
9356461 RGD
enables protein binding IPI
IPI: 通过物理相互作用推断
9356461 RGD
enables protein dimerization activity IPI
IPI: 通过物理相互作用推断
9356461 RGD
enables protein-containing complex binding IPI
IPI: 通过物理相互作用推断
9356461 RGD
生物过程 GO 注释 逻辑证据 参考文献 来源
involved in negative regulation of apoptotic process IDA
IDA: 通过直接分析推断
9356461 RGD
EXP：通过实验结果推断 IDA：通过直接分析推断 IPI：通过物理相互作用推断 IMP：通过突变表型推断 IGI：通过遗传相互作用推断 IEP：通过表达模式推断

Mcl1 蛋白结构

Bcl-2_like

Bcl-2_like: cd06845 (154 - 297)

  • 0
  • 100
  • 200
  • 300
  • 330 a.a.
蛋白主名 其他名称

induced myeloid leukemia cell differentiation protein Mcl-1 homolog

BCL2 family apoptosis regulator

MCL1, BCL2 family apoptosis regulator

myeloid cell leukemia 1

myeloid cell leukemia sequence 1

相关产品

Clinical Phase
生物活性分子 (21)
目录号 产品名 作用方式
纯度 Phase
HY-112041 Unesbulin 99.17% Phase 3
HY-15464A (R)-(-)-Gossypol acetic acid 98.93% Phase 3
HY-101533 AZD-5991 Inhibitor 99.79% Phase 2
HY-112218 MIK665 Inhibitor 99.11% Phase 2
HY-X0009 Tambiciclib 99.21% Phase 2
HY-15464 (R)-(-)-Gossypol 99.37% Phase 2
HY-138697 S65487 99.91% Phase 2
HY-138697A S65487 sulfate 99.35% Phase 2
HY-138697B S65487 hydrochloride 99.67% Phase 2
HY-X0009A Tambiciclib dimaleate / Phase 2
HY-10357 MK-2206 free base / Phase 2
HY-15163A Zotiraciclib hydrochloride Inhibitor / Phase 2
HY-149672 ABBV-467 Inhibitor 99.78% Phase 1
HY-12422 Voruciclib Inhibitor 99.76% Phase 1
HY-101565 Tapotoclax Inhibitor 99.53% Phase 1
HY-103019B (-)-Enitociclib 99.85% Phase 1
HY-109184 Murizatoclax Inhibitor 98.84% Phase 1
HY-12422A Voruciclib hydrochloride Inhibitor 99.23% Phase 1
HY-101533B AZD-5991 (S-enantiomer) Inhibitor 99.83% Phase 1
HY-19471 (rac)-ZK-304709 / Phase 1
HY-103019BR (-)-Enitociclib (Standard) / Phase 1
抗体抑制剂 (1)
目录号 产品名 作用方式
纯度 Phase
HY-P991225 BI-1206 Antagonist 96.82% Phase 2
Pre-clinical Phase
生物活性分子 (153)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-100741 S63845 Inhibitor 99.94% 否
HY-114855 BT2 Inhibitor 99.81% 否
HY-N0662 Amentoflavone 99.66% 否
HY-N0087 Gambogic Acid 98.34% 否
HY-103019 Enitociclib 99.89% 否
HY-18628 UMI-77 Inhibitor 99.66% 否
HY-123954 BTX-A51 98.58% 否
HY-101972 AZ-PFKFB3-67 Inhibitor 97.03% 否
HY-12468 A-1210477 99.86% 否
HY-N0763 Angelicin 99.98% 否
HY-118341 Clitocine 95.88% 否
HY-14985 BAY 61-3606 dihydrochloride 99.45% 否
HY-N0831 Jaceosidin 99.51% 否
HY-W040129 Chromomycin A3 99.66% 否
HY-125877 PROTAC Mcl1 degrader-1 Inhibitor 98.13% 否
HY-125876 PROTAC Bcl2 degrader-1 Inhibitor 99.80% 否
HY-W008296 NH2-C6-NH-Boc 99.61% 否
HY-103019A (±)-Enitociclib 99.23% 否
HY-164515 ONC213 99.89% 否
HY-129478 TC11 99.55% 否
HY-76474A BAY 61-3606 hydrochloride 98.08% 否
HY-15191 Sabutoclax Inhibitor 99.80% 否
HY-153803 GBD-9 Degrader 99.91% 否
HY-12020 TW-37 Inhibitor 99.50% 否
HY-112859 VU0661013 Inhibitor 98.45% 否
HY-162919 YK-2168 98.05% 否
HY-117203A CDK12-IN-E9 Inhibitor 99.71% 否
HY-100741A (S,R)-S63845 Control 98.54% 否
HY-119271 CMLD010509 99.11% 否
HY-149007 STAT3-IN-11 98.29% 否
HY-122627 CLZ-8 99.14% 否
HY-129700 MCL-1/BCL-2-IN-2 Inhibitor 99.05% 否
HY-N8146 Bruceantinol Inhibitor 98.89% 否
HY-129681 MCL-1/BCL-2-IN-1 Inhibitor 98.65% 否
HY-162858 BRD-810 98.00% 否
HY-100741C (R,R)-S63845 Control 99.32% 否
HY-101778 ML311 Inhibitor 98.98% 否
HY-123955 Casein Kinase inhibitor A86 99.26% 否
HY-16695 MIM1 Inhibitor 98.0% 否
HY-P2343 BH3 hydrochloride Activator 98.03% 否
HY-128360 dMCL1-2 99.29% 否
HY-132307 Mcl-1 inhibitor 6 98.77% 否
HY-120113 SC-2001 99.37% 否
HY-155472 Mcl-1 inhibitor 17 Inhibitor 99.41% 否
HY-15613 Maritoclax Inhibitor 99.97% 否
HY-160438B PBX-7011 TFA Inhibitor 98.60% 否
HY-158783 SACLAC 99.70% 否
HY-112591 NSC260594 96.00% 否
HY-129702 MCL-1/BCL-2-IN-4 Inhibitor 99.95% 否
HY-176142 YX0798 98.90% 否
HY-178226 PBX-7016 Inhibitor / 否
HY-167881 MLS-0053105 Inhibitor 98.89% 否
HY-15191B (S)-Sabutoclax Inhibitor 98.03% 否
HY-164460 AZD1897 Inhibitor 99.69% 否
HY-19551 Apogossypolone 98.58% 否
HY-101533A AZD-5991 Racemate Inhibitor / 否
HY-12826 IMB-XH1 Inhibitor 98.0% 否
HY-129701 MCL-1/BCL-2-IN-3 Inhibitor 98.93% 否
HY-13408 (+)-Apogossypol Inhibitor / 否
HY-RS08230 MCL1 Human Pre-designed siRNA Set A / 否
HY-12527 Pyridoclax Inhibitor 99.95% 否
HY-16669 Mcl1-IN-1 Inhibitor 98.02% 否
HY-76474 BAY 61-3606 98.21% 否
HY-112218A (R)-MIK665 Inhibitor / 否
HY-125908 A-1210477-piperazinyl / 否
HY-128607 Mcl1-IN-9 Inhibitor / 否
HY-100762 Mcl1-IN-11 Inhibitor / 否
HY-100763 Mcl1-IN-12 Inhibitor / 否
HY-111537 rel-AZ5576 Inhibitor / 否
HY-130261 Mcl-1 antagonist 1 Antagonist / 否
HY-133015 Mcl-1 inhibitor 3 Inhibitor / 否
HY-139453A LP-284 / 否
HY-145825 Mcl-1 inhibitor 7 Inhibitor / 否
HY-145825A (E)-Mcl-1 inhibitor 7 Inhibitor / 否
HY-146097 RMS5 / 否
HY-171334A P1D-34 / 否
HY-115928 M24 Inhibitor / 否
HY-116220 Mcl1-IN-14 / 否
HY-122721 Mcl1-IN-5 Inhibitor / 否
HY-122759 CPA-7 / 否
HY-123034 CDKI-83 / 否
HY-123564 Mcl1-IN-7 Inhibitor / 否
HY-124846 MI-223 Modulator / 否
HY-125718 MLS-2384 free base / 否
HY-144428 Bcl-2/Mcl-1-IN-2 Inhibitor / 否
HY-144430 Bcl-2/Mcl-1-IN-1 Inhibitor / 否
HY-144431 Bcl-2/Mcl-1-IN-3 Inhibitor / 否
HY-145826 Mcl-1 inhibitor 8 Inhibitor / 否
HY-148203 Mcl-1 inhibitor 9 Inhibitor / 否
HY-148899 Mcl-1 inhibitor 10 Inhibitor / 否
HY-149495 CP-07 Degrader / 否
HY-150507 JNJ-4355 Inhibitor / 否
HY-153423 Mcl-1 inhibitor 12 Inhibitor / 否
HY-153423A Mcl-1 inhibitor 13 Inhibitor / 否
HY-154961 Mcl-1 inhibitor 14 / 否
HY-154962 Mcl-1 inhibitor 15 Inhibitor / 否
HY-155012 Mcl-1 inhibitor 16 Inhibitor / 否
HY-155153 CDK9-IN-24 / 否
HY-155245 A09-003 Inhibitor / 否
HY-15867 Meayamycin B / 否
HY-159513 Bcl-2/Mcl-1-IN-4 Inhibitor / 否
HY-159588 Mcl-1 inhibitor 20 Inhibitor / 否
HY-161274 Bfl-1-IN-1 Inhibitor / 否
HY-161732 GQN-B37-E Inhibitor / 否
HY-161733 GQN-B37-Me Inhibitor / 否
HY-162619 CDK9-IN-33 / 否
HY-162780 Mcl-1-IN-19 Inhibitor / 否
HY-163293 Mcl-1 inhibitor 18 Inhibitor / 否
HY-163681 Zamzetoclax Inhibitor / 否
HY-164452 A-1155905 / 否
HY-164453 A-1248767 / 否
HY-169797 STAT3-IN-38 / 否
HY-170762 Mcl-1 inhibitor 21 Inducer / 否
HY-170762A (+)-Mcl-1 inhibitor 21 Inducer / 否
HY-170762B (-)-Mcl-1 inhibitor 21 Inducer / 否
HY-170763 Mcl-1 inhibitor 22 Inducer / 否
HY-170763A (+)-Mcl-1 inhibitor 22 Inducer / 否
HY-170763B (-)-Mcl-1 inhibitor 22 / 否
HY-173065 CDK9-IN-36 / 否
HY-178008 Mcl-1-IN-16 / 否
HY-178010 Mcl-1-IN-17 Inhibitor / 否
HY-178499 CDK9-IN-44 Inhibitor / 否
HY-178910 Mcl-1-IN-20 / 否
HY-179023 CDK9-IN-45 / 否
HY-179633 ZLMT-72 / 否
HY-180190 Tubulin polymerization-IN-85 / 否
HY-181054 Mcl-1-IN-21 / 否
HY-181078 Cephalotaxine-ester-(R)-1-ethoxy-3-mercaptopropan-2-ol-Ph(3,4OMe) / 否
HY-181587 PDGFRA/CAIX/XII-IN-1 / 否
HY-181746 Bcl-2/Mcl-1-IN-5 / 否
HY-181767 PROTAC HDAC3 degrader-1 / 否
HY-182312 CTX-439 / 否
HY-182671 SRX3305 Inhibitor / 否
HY-18628S UMI-77-d4 Inhibitor / 否
HY-N0831R Jaceosidin (Standard) / 否
HY-N16746 Nordentatin Inhibitor / 否
HY-N17676 3-Tridecylphenol / 否
HY-N3913 Furowanin A Inhibitor / 否
HY-P4095 NoxaBH3 / 否
HY-RS08231 Mcl1 Mouse Pre-designed siRNA Set A / 否
HY-RS08232 Mcl1 Rat Pre-designed siRNA Set A / 否
HY-W043574 6-Ethyl-7-hydroxy-4-methyl-2H-chromen-2-one Inhibitor / 否
HY-W689801 A-1208746 / 否
HY-103019AR (±)-Enitociclib (Standard) / 否
HY-115529 (-)BI97D6 Inducer / 否
HY-116532 YCW-E11 Inhibitor / 否
HY-119009 TM-233 Inhibitor / 否
HY-119271A (-)-CMLD010509 / 否
HY-121638B (E/Z)-CU-3 / 否
HY-164468 Ch282-5 Inhibitor / 否
HY-W286906 Mcl1-IN-15 / 否
HY-111467 Mcl1-IN-4 Inhibitor / 否
HY-111468 Mcl1-IN-3 Inhibitor / 否
抗体抑制剂 (1)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-P991899 IKS03 Antibody / 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens Mcl1 NCBI NCBI:4170
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z